The efficacy and safety of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.

Xing-Hui WangZhi-Qiang WangZhen-Yu MuLi-Ping ZhuChong-Fu ZhongShanchun Guo

Published in: Medicine (2022)

The immune checkpoint inhibitors therapy was well tolerated and showed potential to improve tumor responses in patients with metastatic castration-resistant prostate cancer.

Keyphrases

squamous cell carcinoma
small cell lung cancer
human health
mesenchymal stem cells
smoking cessation
replacement therapy